Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
July 29, 2022 at 03:49 pm IST
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 1,393.57 million compared to CNY 1,250.91 million a year ago. Revenue was CNY 1,395.47 million compared to CNY 1,254.5 million a year ago. Net income was CNY 38.21 million compared to CNY 35.14 million a year ago. Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.23 a year ago. Diluted earnings per share from continuing operations was CNY 0.19 compared to CNY 0.23 a year ago.